fluorodeoxyglucose f18 has been researched along with Cerebral Microangiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, L; Blautzik, J; Brendel, E; Brendel, M; Gutzeit, A; Henkel, R; Paolini, M; Pogarell, O; Rominger, A | 1 |
| Heiss, WD | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Cerebral Microangiopathies
| Article | Year |
|---|---|
The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease.
Topics: Amyloidogenic Proteins; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Dementia, Vascular; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Synaptic Transmission; tau Proteins | 2018 |
1 other study(ies) available for fluorodeoxyglucose f18 and Cerebral Microangiopathies
| Article | Year |
|---|---|
FDG PET Data is Associated with Cognitive Performance in Patients from a Memory Clinic.
Topics: Aged; Aged, 80 and over; Cerebral Small Vessel Diseases; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Germany; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |